HarryADrabkinMD

Grant Support

• SEMA3F And ZEB1 In Lung Cancer: Therapy And Target Gene DiscoveryNational Cancer Institute2008–2011
• DNA Sequencing &Analysis CoreNational Cancer Institute2006–2010
• Quantitative HOX Expression As Prognostic Marker In AMLNational Cancer Institute2004–2006
• Molecular-Genetic Analysis Of 3p14 Genomic StabilityNational Cancer Institute1998–2006
• Alterations Of E-Cadherin And Proteasome Function In Progression Of Lung CancerNational Cancer Institute2003
• Quantitative HOX Expression As Prognostic Marker In AMLNational Cancer Institute2002
• Core--Dna Sequencing And AnalysisNational Cancer Institute2001–2002
• Core--Dna SequencingNational Cancer Institute1996–2000
• Chromosome 3p211 RegionNational Cancer Institute1995–1997
• Characterization Of AML1/ETO Genes In T(8;21) Acute Myelogenous LeukemiaEunice Kennedy Shriver National Institute Of Child Health &Human Development1993–1997
• Physical MAP And Contigs For Human Chromosome 3National Human Genome Research Institute1991–1996
• Characterization Of The Chromosome 3p14 3p21.1 RegionEunice Kennedy Shriver National Institute Of Child Health &Human Development1991–1994
• Rearrangement In Human Leukkemia And Physical MappingEunice Kennedy Shriver National Institute Of Child Health &Human Development1988–1992
• Construction Of A Physical MAP For Human Chromosome 3National Human Genome Research Institute1990
• Characterization Of The Chromosome 3p14-21 RegionEunice Kennedy Shriver National Institute Of Child Health &Human Development1988–1990
• Construction Of A Physical MAP For Human Chromosome 3National Institute Of General Medical Sciences1988–1989
• Molecular Analysis Of Renal Cell Carcinoma Chromosome 3 DeletionNational Center For Research Resources1988
• Molecular Analysis Of The Renal Cell Carcinoma ChromosomeNational Center For Research Resources1987
• NCI Clinical Investigator Award ProgramNational Cancer Institute1985–1987